 | | 83V | | 表記: | (4S)-4-amino-6-phenylhexanoic acid | | 組成式: | C12 H17 N O2 | | SMILES: | O=C(O)CCC(N)CCc1ccccc1 | | InChi: | InChI=1S/C12H17NO2/c13-11(8-9-12(14)15)7-6-10-4-2-1-3-5-10/h1-5,11H,6-9,13H2,(H,14,15)/t11-/m0/s1 | | 定義日: | 2021-09-03 | | 最終更新日: | 2022-02-25 | | 公開日: | 2022-03-02 | | 識別子（ID）: | (4S)-4-amino-6-phenylhexanoic acid |
|
 | | 84H | | 表記: | (5S)-5-[([1,1'-biphenyl]-4-yl)methyl]-4-methoxy-1,5-dihydro-2H-pyrrol-2-one | | 組成式: | C18 H17 N O2 | | SMILES: | O=C1C=C(OC)C(Cc2ccc(cc2)c2ccccc2)N1 | | InChi: | InChI=1S/C18H17NO2/c1-21-17-12-18(20)19-16(17)11-13-7-9-15(10-8-13)14-5-3-2-4-6-14/h2-10,12,16H,11H2,1H3,(H,19,20)/t16-/m0/s1 | | 定義日: | 2021-09-03 | | 最終更新日: | 2022-02-25 | | 公開日: | 2022-03-02 | | 識別子（ID）: | (5S)-5-[([1,1'-biphenyl]-4-yl)methyl]-4-methoxy-1,5-dihydro-2H-pyrrol-2-one |
|
 | | 84N | | 表記: | (5S)-5-[(1H-indol-3-yl)methyl]-4-methoxy-1,5-dihydro-2H-pyrrol-2-one | | 組成式: | C14 H14 N2 O2 | | SMILES: | O=C1C=C(OC)C(Cc2c[NH]c3ccccc23)N1 | | InChi: | InChI=1S/C14H14N2O2/c1-18-13-7-14(17)16-12(13)6-9-8-15-11-5-3-2-4-10(9)11/h2-5,7-8,12,15H,6H2,1H3,(H,16,17)/t12-/m0/s1 | | 定義日: | 2021-09-03 | | 最終更新日: | 2022-02-25 | | 公開日: | 2022-03-02 | | 識別子（ID）: | (5S)-5-[(1H-indol-3-yl)methyl]-4-methoxy-1,5-dihydro-2H-pyrrol-2-one |
|
 | | 8CK | | 表記: | N-(4-fluorophenyl)-4,5-dimethyl-6-[(1R)-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]pyrimidin-2-amine | | 組成式: | C22 H23 F N4 | | SMILES: | C[CH]1N(CCc2ccccc12)c3nc(Nc4ccc(F)cc4)nc(C)c3C | | InChi: | InChI=1S/C22H23FN4/c1-14-15(2)24-22(25-19-10-8-18(23)9-11-19)26-21(14)27-13-12-17-6-4-5-7-20(17)16(27)3/h4-11,16H,12-13H2,1-3H3,(H,24,25,26)/t16-/m1/s1 | | 別名: | R-revaprazan | | 定義日: | 2021-12-03 | | 最終更新日: | 2022-02-25 | | 公開日: | 2022-03-02 | | 識別子（ID）: | ~{N}-(4-fluorophenyl)-4,5-dimethyl-6-[(1~{R})-1-methyl-3,4-dihydro-1~{H}-isoquinolin-2-yl]pyrimidin-2-amine |
|
 | | 8QI | | 表記: | ({(2S)-3-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-2-[(2S)-2-hydroxy-2-phosphonoethoxy]propoxy}methyl)phosphonic acid | | 組成式: | C11 H19 N5 O10 P2 | | SMILES: | O=P(O)(O)COCC(OCC(O)P(=O)(O)O)Cn1cnc2c1N=C(N)NC2=O | | InChi: | InChI=1S/C11H19N5O10P2/c12-11-14-9-8(10(18)15-11)13-4-16(9)1-6(2-25-5-27(19,20)21)26-3-7(17)28(22,23)24/h4,6-7,17H,1-3,5H2,(H2,19,20,21)(H2,22,23,24)(H3,12,14,15,18)/t6-,7-/m0/s1 | | 定義日: | 2021-09-24 | | 最終更新日: | 2022-02-25 | | 公開日: | 2022-03-02 | | 識別子（ID）: | ({(2S)-3-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-2-[(2S)-2-hydroxy-2-phosphonoethoxy]propoxy}methyl)phosphonic acid |
|
 | | IRK | | 表記: | (1R,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-2-{[N-({[(1R,2S)-2-propylcyclopropyl]methoxy}carbonyl)-L-leucyl]amino}propane-1-sulfonic acid | | 組成式: | C21 H37 N3 O8 S | | SMILES: | CC(C)CC(NC(=O)OCC1CC1CCC)C(=O)NC(CC1CCNC1=O)C(O)S(=O)(=O)O | | InChi: | InChI=1S/C21H37N3O8S/c1-4-5-13-9-15(13)11-32-21(28)24-16(8-12(2)3)19(26)23-17(20(27)33(29,30)31)10-14-6-7-22-18(14)25/h12-17,20,27H,4-11H2,1-3H3,(H,22,25)(H,23,26)(H,24,28)(H,29,30,31)/t13-,14-,15-,16-,17-,20+/m0/s1 | | 定義日: | 2022-01-27 | | 最終更新日: | 2022-02-25 | | 公開日: | 2022-03-02 | | 識別子（ID）: | (1R,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-2-{[N-({[(1R,2S)-2-propylcyclopropyl]methoxy}carbonyl)-L-leucyl]amino}propane-1-sulfonic acid |
|
 | | IUB | | 表記: | (1S,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-2-{[N-({[(1R,2S)-2-propylcyclopropyl]methoxy}carbonyl)-L-leucyl]amino}propane-1-sulfonic acid | | 組成式: | C21 H37 N3 O8 S | | SMILES: | CC(C)CC(NC(=O)OCC1CC1CCC)C(=O)NC(CC1CCNC1=O)C(O)S(=O)(=O)O | | InChi: | InChI=1S/C21H37N3O8S/c1-4-5-13-9-15(13)11-32-21(28)24-16(8-12(2)3)19(26)23-17(20(27)33(29,30)31)10-14-6-7-22-18(14)25/h12-17,20,27H,4-11H2,1-3H3,(H,22,25)(H,23,26)(H,24,28)(H,29,30,31)/t13-,14-,15-,16-,17-,20-/m0/s1 | | 定義日: | 2022-01-28 | | 最終更新日: | 2022-02-25 | | 公開日: | 2022-03-02 | | 識別子（ID）: | (1S,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-2-{[N-({[(1R,2S)-2-propylcyclopropyl]methoxy}carbonyl)-L-leucyl]amino}propane-1-sulfonic acid |
|
 | | UE8 | | 表記: | 2-sulfanylidene-3-[(2R)-tetrahydro-2-furanylmethyl]-1,2,3,7-tetrahydro-6H-purin-6-one | | 組成式: | C10 H12 N4 O2 S | | SMILES: | O=C1NC(=S)N(C[CH]2CCCO2)c3[nH]cnc13 | | InChi: | InChI=1S/C10H12N4O2S/c15-9-7-8(12-5-11-7)14(10(17)13-9)4-6-2-1-3-16-6/h5-6H,1-4H2,(H,11,12)(H,13,15,17)/t6-/m1/s1 | | 別名: | 3-[[(2~{R})-oxolan-2-yl]methyl]-2-sulfanylidene-9~{H}-purin-6-one | | 定義日: | 2021-02-11 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | 3-[[(2~{R})-oxolan-2-yl]methyl]-2-sulfanylidene-9~{H}-purin-6-one |
|
 | | UEB | | 表記: | (S)-1-(2-(amino(phenyl)methyl)benzyl)-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-one | | 組成式: | C20 H18 N4 O S | | SMILES: | N[CH](c1ccccc1)c2ccccc2CN3C(=S)NC(=O)c4[nH]ccc34 | | InChi: | InChI=1S/C20H18N4OS/c21-17(13-6-2-1-3-7-13)15-9-5-4-8-14(15)12-24-16-10-11-22-18(16)19(25)23-20(24)26/h1-11,17,22H,12,21H2,(H,23,25,26)/t17-/m1/s1 | | 別名: | 1-[[2-[(~{R})-azanyl(phenyl)methyl]phenyl]methyl]-2-sulfanylidene-5~{H}-pyrrolo[3,2-d]pyrimidin-4-one | | 定義日: | 2021-02-11 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | 1-[[2-[(~{R})-azanyl(phenyl)methyl]phenyl]methyl]-2-sulfanylidene-5~{H}-pyrrolo[3,2-d]pyrimidin-4-one |
|
 | | RY5 | | 表記: | (3~{S})-6-chloranyl-3'-(1,2-oxazol-3-ylmethyl)spiro[1,2-dihydroindene-3,5'-imidazolidine]-2',4'-dione | | 組成式: | C15 H12 Cl N3 O3 | | SMILES: | Clc1ccc2c(CC[C]23NC(=O)N(Cc4ccon4)C3=O)c1 | | InChi: | InChI=1S/C15H12ClN3O3/c16-10-1-2-12-9(7-10)3-5-15(12)13(20)19(14(21)17-15)8-11-4-6-22-18-11/h1-2,4,6-7H,3,5,8H2,(H,17,21)/t15-/m0/s1 | | 定義日: | 2020-11-02 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | (3~{S})-6-chloranyl-3'-(1,2-oxazol-3-ylmethyl)spiro[1,2-dihydroindene-3,5'-imidazolidine]-2',4'-dione |
|
 | | XRF | | 表記: | 1-{2-deoxy-5-O-[(S)-hydroxy{[(S)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-L-erythro-pentofuranosyl}-5-methylpyrimidine-2,4(1H,3H)-dione | | 組成式: | C10 H17 N2 O14 P3 | | SMILES: | O=P(O)(O)OP(=O)(O)OP(=O)(O)OCC1OC(CC1O)N1C=C(C)C(=O)NC1=O | | InChi: | InChI=1S/C10H17N2O14P3/c1-5-3-12(10(15)11-9(5)14)8-2-6(13)7(24-8)4-23-28(19,20)26-29(21,22)25-27(16,17)18/h3,6-8,13H,2,4H2,1H3,(H,19,20)(H,21,22)(H,11,14,15)(H2,16,17,18)/t6-,7+,8+/m1/s1 | | 定義日: | 2021-03-09 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | 1-{2-deoxy-5-O-[(S)-hydroxy{[(S)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-L-erythro-pentofuranosyl}-5-methylpyrimidine-2,4(1H,3H)-dione |
|
 | | V18 | | 表記: | 2-cyclobutyl-7-isoquinolin-4-yl-5,7-diazaspiro[3.4]octane-6,8-dione | | 組成式: | C19 H19 N3 O2 | | SMILES: | O=C1N[C]2(C[CH](C2)C3CCC3)C(=O)N1c4cncc5ccccc45 | | InChi: | InChI=1S/C19H19N3O2/c23-17-19(8-14(9-19)12-5-3-6-12)21-18(24)22(17)16-11-20-10-13-4-1-2-7-15(13)16/h1-2,4,7,10-12,14H,3,5-6,8-9H2,(H,21,24)/t14-,19- | | 定義日: | 2021-04-06 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | 2-cyclobutyl-7-isoquinolin-4-yl-5,7-diazaspiro[3.4]octane-6,8-dione |
|
 | | YAV | | 表記: | 2-[2-[2-[3-[2-[2-[2-[[3-[2-[3-(2-hydroxy-2-oxoethyl)-5-methyl-1-benzofuran-2-yl]ethynyl]phenyl]carbonylamino]ethoxy]ethoxy]ethylcarbamoyl]phenyl]ethynyl]-5-methyl-1-benzofuran-3-yl]ethanoic acid | | 組成式: | C46 H40 N2 O10 | | SMILES: | Cc1ccc2oc(C#Cc3cccc(c3)C(=O)NCCOCCOCCNC(=O)c4cccc(c4)C#Cc5oc6ccc(C)cc6c5CC(O)=O)c(CC(O)=O)c2c1 | | InChi: | InChI=1S/C46H40N2O10/c1-29-9-13-39-35(23-29)37(27-43(49)50)41(57-39)15-11-31-5-3-7-33(25-31)45(53)47-17-19-55-21-22-56-20-18-48-46(54)34-8-4-6-32(26-34)12-16-42-38(28-44(51)52)36-24-30(2)10-14-40(36)58-42/h3-10,13-14,23-26H,17-22,27-28H2,1-2H3,(H,47,53)(H,48,54)(H,49,50)(H,51,52) | | 定義日: | 2021-02-15 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | 2-[2-[2-[3-[2-[2-[2-[[3-[2-[3-(2-hydroxy-2-oxoethyl)-5-methyl-1-benzofuran-2-yl]ethynyl]phenyl]carbonylamino]ethoxy]ethoxy]ethylcarbamoyl]phenyl]ethynyl]-5-methyl-1-benzofuran-3-yl]ethanoic acid |
|
 | | V1B | | 表記: | 7-isoquinolin-4-yl-2-phenyl-5,7-diazaspiro[3.4]octane-6,8-dione | | 組成式: | C21 H17 N3 O2 | | SMILES: | O=C1N[C]2(C[CH](C2)c3ccccc3)C(=O)N1c4cncc5ccccc45 | | InChi: | InChI=1S/C21H17N3O2/c25-19-21(10-16(11-21)14-6-2-1-3-7-14)23-20(26)24(19)18-13-22-12-15-8-4-5-9-17(15)18/h1-9,12-13,16H,10-11H2,(H,23,26)/t16-,21+ | | 定義日: | 2021-04-06 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | 7-isoquinolin-4-yl-2-phenyl-5,7-diazaspiro[3.4]octane-6,8-dione |
|
 | | YFA | | 表記: | (2R)-2-{5-fluoro-6-[4-(1-methylpiperidin-4-yl)phenyl]-4-oxoquinazolin-3(4H)-yl}-2-phenyl-N-(1,3-thiazol-2-yl)acetamide | | 組成式: | C31 H28 F N5 O2 S | | SMILES: | C(C(N4C(c3c(c(c2ccc(C1CCN(C)CC1)cc2)ccc3N=C4)F)=O)c5ccccc5)(Nc6nccs6)=O | | InChi: | InChI=1S/C31H28FN5O2S/c1-36-16-13-21(14-17-36)20-7-9-22(10-8-20)24-11-12-25-26(27(24)32)30(39)37(19-34-25)28(23-5-3-2-4-6-23)29(38)35-31-33-15-18-40-31/h2-12,15,18-19,21,28H,13-14,16-17H2,1H3,(H,33,35,38)/t28-/m1/s1 | | 定義日: | 2021-02-24 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | (2R)-2-{5-fluoro-6-[4-(1-methylpiperidin-4-yl)phenyl]-4-oxoquinazolin-3(4H)-yl}-2-phenyl-N-(1,3-thiazol-2-yl)acetamide |
|
 | | BKU | | 表記: | (1S,2S,3S,5R,6S,16E,18E,20S,21R)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1~10,14~.0~3,5~]hexacosa-10(26),11,13,16,18-pentaen-6-yl (2S)-2-{methyl[3-methyl-3-(methyldisulfanyl)butanoyl]amino}propanoate (non-preferred name) | | 組成式: | C38 H54 Cl N3 O10 S2 | | SMILES: | c42cc(OC)c(Cl)c(N(C)C(=O)CC(C1(C)OC1C(C)C3OC(NC(C(OC)C=CC=C(C2)C)(C3)O)=O)OC(=O)C(C)N(C)C(=O)CC(C)(C)SSC)c4 | | InChi: | InChI=1S/C38H54ClN3O10S2/c1-21-13-12-14-28(49-10)38(47)19-27(50-35(46)40-38)22(2)33-37(6,52-33)29(51-34(45)23(3)41(7)31(44)20-36(4,5)54-53-11)18-30(43)42(8)25-16-24(15-21)17-26(48-9)32(25)39/h12-14,16-17,22-23,27-29,33,47H,15,18-20H2,1-11H3,(H,40,46)/b14-12+,21-13+/t22-,23-,27-,28-,29-,33-,37+,38+/m0/s1 | | 定義日: | 2019-02-20 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | (1S,2S,3S,5R,6S,16E,18E,20S,21R)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1~10,14~.0~3,5~]hexacosa-10(26),11,13,16,18-pentaen-6-yl (2S)-2-{methyl[3-methyl-3-(methyldisulfanyl)butanoyl]amino}propanoate (non-preferred name) |
|
 | | SQ2 | | 表記: | 2-(1H-1,2,3-benzotriazol-1-yl)-1-(4-methylpiperidin-1-yl)ethan-1-one | | 組成式: | C14 H18 N4 O | | SMILES: | CC1CCN(CC1)C(=O)Cn2nnc3ccccc23 | | InChi: | InChI=1S/C14H18N4O/c1-11-6-8-17(9-7-11)14(19)10-18-13-5-3-2-4-12(13)15-16-18/h2-5,11H,6-10H2,1H3 | | 別名: | 2-(benzotriazol-1-yl)-1-(4-methylpiperidin-1-yl)ethanone | | 定義日: | 2020-11-27 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | 2-(benzotriazol-1-yl)-1-(4-methylpiperidin-1-yl)ethanone |
|
 | | SQ5 | | 表記: | (5S)-5-(cyclohexylmethyl)-3-(5-fluoropyridin-3-yl)imidazolidine-2,4-dione | | 組成式: | C15 H18 F N3 O2 | | SMILES: | Fc1cncc(c1)N2C(=O)N[CH](CC3CCCCC3)C2=O | | InChi: | InChI=1S/C15H18FN3O2/c16-11-7-12(9-17-8-11)19-14(20)13(18-15(19)21)6-10-4-2-1-3-5-10/h7-10,13H,1-6H2,(H,18,21)/t13-/m0/s1 | | 別名: | (5~{S})-5-(cyclohexylmethyl)-3-(5-fluoranylpyridin-3-yl)imidazolidine-2,4-dione | | 定義日: | 2020-11-27 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | (5~{S})-5-(cyclohexylmethyl)-3-(5-fluoranylpyridin-3-yl)imidazolidine-2,4-dione |
|
 | | SYH | | 表記: | 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-methylenepiperidin-1-yl)ethan-1-one | | 組成式: | C14 H16 N4 O | | SMILES: | C=C1CCN(CC1)C(=O)Cn2nnc3ccccc23 | | InChi: | InChI=1S/C14H16N4O/c1-11-6-8-17(9-7-11)14(19)10-18-13-5-3-2-4-12(13)15-16-18/h2-5H,1,6-10H2 | | 別名: | 2-(1H-1,2,3-benzotriazol-1-yl)-1-(4-methylidenepiperidin-1-yl)ethan-1-one | | 定義日: | 2020-12-07 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | 2-(benzotriazol-1-yl)-1-(4-methylidenepiperidin-1-yl)ethanone |
|
 | | T0W | | 表記: | 2-(benzotriazol-1-yl)-~{N}-ethyl-~{N}-(furan-3-ylmethyl)ethanamide | | 組成式: | C15 H16 N4 O2 | | SMILES: | CCN(Cc1cocc1)C(=O)Cn2nnc3ccccc23 | | InChi: | InChI=1S/C15H16N4O2/c1-2-18(9-12-7-8-21-11-12)15(20)10-19-14-6-4-3-5-13(14)16-17-19/h3-8,11H,2,9-10H2,1H3 | | 別名: | 2-(1H-1,2,3-benzotriazol-1-yl)-N-ethyl-N-[(furan-3-yl)methyl]acetamide | | 定義日: | 2020-12-09 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | 2-(benzotriazol-1-yl)-~{N}-ethyl-~{N}-(furan-3-ylmethyl)ethanamide |
|
 | | GF6 | | 表記: | 1-[3-(trifluoromethyl)phenyl]urea | | 組成式: | C8 H7 F3 N2 O | | SMILES: | NC(=O)Nc1cccc(c1)C(F)(F)F | | InChi: | InChI=1S/C8H7F3N2O/c9-8(10,11)5-2-1-3-6(4-5)13-7(12)14/h1-4H,(H3,12,13,14) | | 定義日: | 2020-08-26 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | 1-[3-(trifluoromethyl)phenyl]urea |
|
 | | TU8 | | 表記: | (3~{S})-3'-(5-fluoranylpyridin-3-yl)spiro[1,2-dihydroindene-3,5'-imidazolidine]-2',4'-dione | | 組成式: | C16 H12 F N3 O2 | | SMILES: | Fc1cncc(c1)N2C(=O)N[C]3(CCc4ccccc34)C2=O | | InChi: | InChI=1S/C16H12FN3O2/c17-11-7-12(9-18-8-11)20-14(21)16(19-15(20)22)6-5-10-3-1-2-4-13(10)16/h1-4,7-9H,5-6H2,(H,19,22)/t16-/m0/s1 | | 定義日: | 2021-01-13 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | (3~{S})-3'-(5-fluoranylpyridin-3-yl)spiro[1,2-dihydroindene-3,5'-imidazolidine]-2',4'-dione |
|
 | | U7W | | 表記: | 2-(benzotriazol-1-yl)-1-[(4~{S})-4-methyl-6,7-dihydro-4~{H}-thieno[3,2-c]pyridin-5-yl]ethanone | | 組成式: | C16 H16 N4 O S | | SMILES: | C[CH]1N(CCc2sccc12)C(=O)Cn3nnc4ccccc34 | | InChi: | InChI=1S/C16H16N4OS/c1-11-12-7-9-22-15(12)6-8-19(11)16(21)10-20-14-5-3-2-4-13(14)17-18-20/h2-5,7,9,11H,6,8,10H2,1H3/t11-/m0/s1 | | 定義日: | 2021-01-28 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | 2-(benzotriazol-1-yl)-1-[(4~{S})-4-methyl-6,7-dihydro-4~{H}-thieno[3,2-c]pyridin-5-yl]ethanone |
|
 | | U9H | | 表記: | 2-cyclobutyl-7-(5-fluoropyridin-3-yl)-5,7-diazaspiro[3.4]octane-6,8-dione | | 組成式: | C15 H16 F N3 O2 | | SMILES: | Fc1cncc(c1)N2C(=O)N[C]3(C[CH](C3)C4CCC4)C2=O | | InChi: | InChI=1S/C15H16FN3O2/c16-11-4-12(8-17-7-11)19-13(20)15(18-14(19)21)5-10(6-15)9-2-1-3-9/h4,7-10H,1-3,5-6H2,(H,18,21)/t10-,15- | | 別名: | 2-cyclobutyl-7-(5-fluoranylpyridin-3-yl)-5,7-diazaspiro[3.4]octane-6,8-dione | | 定義日: | 2021-02-04 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | 2-cyclobutyl-7-(5-fluoranylpyridin-3-yl)-5,7-diazaspiro[3.4]octane-6,8-dione |
|
 | | U9T | | 表記: | ~{N}-[2-(2-fluorophenyl)ethyl]-4-methyl-piperidine-1-carboxamide | | 組成式: | C15 H21 F N2 O | | SMILES: | CC1CCN(CC1)C(=O)NCCc2ccccc2F | | InChi: | InChI=1S/C15H21FN2O/c1-12-7-10-18(11-8-12)15(19)17-9-6-13-4-2-3-5-14(13)16/h2-5,12H,6-11H2,1H3,(H,17,19) | | 定義日: | 2021-02-09 | | 最終更新日: | 2022-02-18 | | 公開日: | 2022-02-23 | | 識別子（ID）: | ~{N}-[2-(2-fluorophenyl)ethyl]-4-methyl-piperidine-1-carboxamide |
|
